tRNA-derived fragments and their roles in multiple myeloma | OTT
Multiple myeloma (MM) is the second most common hematological malignancy and is characterized by the accumulation of malignant plasma cells in the bone marrow. With the advent of new drugs, such as proteasome inhibitors and immunomodulatory agents, the outcomes of patients with MM have steadily improved.
-
Mark FeslerApril 25, 2021Interesting area of research identifying rna sequences that may play a role in myeloma pathogenesis